psychedelethics Profile Banner
HOPE Profile
HOPE

@psychedelethics

Followers
279
Following
441
Media
32
Statuses
342

Hub @UniofOxford for Psychedelic Ethics (HOPE). News & info on ethics, law & social policy of psychedelics. Led by @briandavidearp @ExistWell via @OxNeuroEthics

Oxford, England
Joined July 2022
Don't wanna be here? Send us removal request.
@ExistWell
David B. Yaden
1 day
New article published in @JAMAHealthForum that examines and critiques 4 aspects of the current pathwork of regulations covering access to psychedelics––and then provides constructive, sensible, and actionable ways forward for each. Work led by drug policy expert @CaleighPropes
@Katherine_Chg
Katherine Cheung
4 days
Was a lot of fun to work on "Gaps in US Psychedelic Policy and How to Close Them" led by @CaleighPropes, with @ExistWell, @MattDEisenberg https://t.co/bWJdEDcWf2
0
7
8
@Katherine_Chg
Katherine Cheung
26 days
Addressing US Demand for Psychedelic Medicines in the Face of Scientific Uncertainty https://t.co/yaFqsKGQTT
Tweet card summary image
cambridge.org
Addressing US Demand for Psychedelic Medicines in the Face of Scientific Uncertainty
0
3
6
@eddietalksdrugs
Eddie Talks Drugs
28 days
Couldn't be more excited to start this new chapter with @ExistWell and the team at @JHPsychedelics! Let's go!! 🚀🍄🧠🔬
@JHPsychedelics
Johns Hopkins Psychedelic Research Center
29 days
Welcome our new post-doctoral research fellow, Dr. Eddie Jacobs @eddietalksdrugs. Dr. Jacobs comes to us from @OxPsychiatry where he investigated ethical aspects of psychedelic therapies. At the CPCR, his work will explore how pre-existing worldviews and beliefs influence the
3
5
20
@bioethics_net
The American Journal of Bioethics
2 years
Our latest editorial: "The Hopkins-Oxford Psychedelics Ethics (HOPE) Working Group Consensus Statement" The first Hopkins-Oxford Psychedelic Ethics (HOPE) workshop convened to discuss ethical matters relating to psychedelics in Aug 2023 at U of Oxford. https://t.co/9IyQcOPVzx
Tweet card summary image
tandfonline.com
Published in The American Journal of Bioethics (Vol. 24, No. 7, 2024)
1
8
21
@eddietalksdrugs
Eddie Talks Drugs
2 years
Which is why we're hosting the statement itself in six languages at https://t.co/gzm9i6ZAMv. There’s much more to it than a twitter thread can do justice, so here’s a preview of the contents. As we acknowledge in the statement, getting psychedelic ethics right is going to need…
1
2
6
@Katherine_Chg
Katherine Cheung
4 months
As the field progresses, the notion of an “enhanced consent form” for psychedelic ICDs may be an empirically testable question that requires more unpacking.
1
2
6
@briandavidearp
Brian D. Earp, Ph.D.
3 months
Social Value Communication Amidst the "Hype" of Psychedelic Research
0
3
7
@moralsciencelab
Moral Science Lab
3 months
🌍 We’re still inviting collaborators—especially from underrepresented regions—to join our cross-cultural replication project. @briandavidearp @bioxphi
@moralsciencelab
Moral Science Lab
3 months
If you'd like to be involved in crosscultural research in #bioxphi, consider joining the global bioxphi research initiative! Link provided in the comment below.
0
7
8
@Katherine_Chg
Katherine Cheung
3 months
"Building standards of psychedelic care: Qualitative examination of expert perspectives on safety, inclusion, and accountability" https://t.co/XqacSVBTqm
0
3
7
@RCarhartHarris
Robin Carhart-Harris
3 months
Eek! A dose of therapy with psilocybin - A meta-analysis of the relationshi... https://t.co/SHLkZap2G5
8
7
69
@Katherine_Chg
Katherine Cheung
4 months
Overall, all forms were long & scored as difficult on readability scales. We note that including too much information can potentially overload a participant, & that the most comprehensive ICDs do not necessarily lead to the greatest participant understanding
1
2
7
@psychedelethics
HOPE
4 months
New publication, in press 🚨Psychedelics Beyond Medicine: Treatment, Enhancement, Hype, Consent, and the Limits of Medicalization - led by @Katherine_Chg, Mina Caraccio, Sebastian Porsdam Mann, with @ExistWell @psychedelethics and others in @JournalPHP https://t.co/GA1o9935Hx
0
6
14
@Katherine_Chg
Katherine Cheung
4 months
With @CaleighPropes, @MariannaGrazz, Kyle Patch & @ExistWell, we reviewed ICDs from psilocybin clinical trials across the U.S., and provided a systematic qualitative description of these ICDs.
1
5
5
@Katherine_Chg
Katherine Cheung
4 months
New paper thread! 🧵 Many have called for “enhanced” informed consent documents (ICD) for psychedelic research & treatments, with growing calls for tailored ICDs in the psychedelic bioethics lit. But how closely do ICDs in psychedelic clinical trials reflect these proposals?
3
9
29
@psychedelethics
HOPE
4 months
New publication, in press 🚨Psychedelics Beyond Medicine: Treatment, Enhancement, Hype, Consent, and the Limits of Medicalization - led by @Katherine_Chg, Mina Caraccio, Sebastian Porsdam Mann, with @ExistWell @psychedelethics and others in @JournalPHP https://t.co/GA1o9935Hx
0
6
14
@Psyched_Alpha
Psychedelic Alpha
6 months
📚✨ ~500 Papers. ~30 Researchers & Experts. One Annotated Psychedelics Bibliography... Introducing the 2024 edition of Psychedelic Alpha's Interdisciplinary Annotated Psychedelic Research Bibliography, by @MichaelHaichin. https://t.co/StiIQ8gbuF
1
8
29
@JHPsychedelics
Johns Hopkins Psychedelic Research Center
6 months
Do you have experience with psychedelic integration? Share your knowledge and experiences in the anonymous questionnaires below to help advance our understanding of how to promote healing, growth, and transformation through psychedelic integration. https://t.co/sIo8exngob
4
5
24